SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,472.33 879.09
( 1.23%)

Global Indices

Nasdaq

51,671.07 418.43
(0.82%)

Dow Jones

7,831.57 45.21
(0.58%)

Hang Seng

69,084.74 42.63
(0.06%)

Nikkei 225

10,559.70 118.10
(1.13%)

Forex

USD-INR

96.78 0.11
(0.12%)

EUR-INR

108.39 0.07
(0.07%)

GBP-INR

127.86 0.00
(0.00%)

JPY-INR

0.61 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

509079

INE742B01025

66.2311355

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUFICBIO

55.23

4059.44

EPS(TTM)

Face Value()

Div & Yield %

7.33

0.02

Back

sharanam infraproject & trading ltd

Plastiblends India standalone net profit rises 44.83% in the March 2026 quarter

Apr 28,2026

Net profit of Plastiblends India rose 44.83% to Rs 13.86 crore in the quarter ended March 2026 as against Rs 9.57 crore during the previous quarter ended March 2025. Sales rose 5.75% to Rs 210.62 crore in the quarter ended March 2026 as against Rs 199.16 crore during the previous quarter ended March 2025.

For the full year,net profit rose 9.72% to Rs 36.69 crore in the year ended March 2026 as against Rs 33.44 crore during the previous year ended March 2025. Sales rose 1.05% to Rs 788.66 crore in the year ended March 2026 as against Rs 780.45 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	210.62	199.16	6	788.66	780.45	1
OPM %	9.02	7.25	-	6.72	6.66	-
PBDT	22.00	16.57	33	63.91	60.14	6
PBT	18.32	12.78	43	48.82	44.92	9
NP	13.86	9.57	45	36.69	33.44	10

72,472.33 879.09 ( 1.23%)

51,671.07 418.43 (0.82%)

7,831.57 45.21 (0.58%)

69,084.74 42.63 (0.06%)

10,559.70 118.10 (1.13%)

96.78 0.11 (0.12%)

108.39 0.07 (0.07%)

127.86 0.00 (0.00%)

0.61 0.00 (0.21%)